1-(2-(N-Methylsulfamoyl)ethyl) naratriptan(1346746-73-3)
- Name: 1-(2-(N-Methylsulfamoyl)ethyl) naratriptan
- Synonyms:1-(2-(N-Methylsulfamoyl)ethyl) naratriptan;1346746-73-3;UNII-YE26H8DS3H;YE26H8DS3H;1H-Indole-1,5-diethanesulfonamide, N1,N5-dimethyl-3-(1-methyl-4-piperidinyl)-;2,2'-(3-(1-Methylpiperidin-4-yl)-1H-indole-1,5-diyl)bis(N-methylethanesulfonamide);2-(3-(1-Methylpiperidin-4-yl)-5-(2-methylsulfamoyl-ethyl)-indol-1-yl)ethanesulfonic acid methylamide;N-methyl-2-[3-(1-methylpiperidin-4-yl)-1-[2-(methylsulfamoyl)ethyl]indol-5-yl]ethanesulfonamide;Naratriptan hydrochloride impurity, 2-(3-(1-methylpiperidin-4-yl)-5-(2-methylsulfamoyl-ethyl)-indol-1-yl)ethanesulfonic acid methylamide- [USP];Naratriptan Impurity E;BCP25675;Q27294481;NARATRIPTAN HYDROCHLORIDE IMPURITY, 2-(3-(1-METHYLPIPERIDIN-4-YL)-5-(2-METHYLSULFAMOYL-ETHYL)-INDOL-1-YL)ETHANESULFONIC ACID METHYLAMIDE- [USP IMPURITY]
- Molecular Formula:C20H32N4O4S2
- Molecular Weight:456.6
- CAS Registry Number:1346746-73-3
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1346746-73-3 Naratriptan Impurity 13
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Application:for drug impurities, for drug standards,for drug research and development
Min. Order:0
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)] 
Premium
SupplierTel:+86-173-20513646
Address:Company address: Room 005, 15th Floor, Building D2, Phase III, Software New Town, No. 8 Huacheng Avenue, East Lake High-tech Development Zone, Wuhan, Hubei Province, China
- Contact Suppliers
Other Product
- 1142201-95-3/4-[(2-Chloro-4-fluorobenzyl)oxy]-3-ethoxybenzoic acid
- 467249-26-9/4-Amino-1-benzoylpyrimidin-2(1H)-one
- 898761-66-5/3-(4-Bromophenyl)-1-(3-chloro-4-fluorophenyl)propan-1-one
- 77864-13-2/(3Z,11Z)-1,3,9,11-tetrazatricyclo[10.4.0.04,9]hexadeca-3,5,7,11,13,15-hexaene-2,10-dithione
- 1384871-32-2/Ethyl 4-bromo-6-methylpyridine-3-carboxylate
- 1262007-52-2/3-[4-(N,N-Dimethylaminocarbonyl)phenyl]isonicotinic acid
- 333384-99-9/2-Methyl-3-(methylsulfanylmethyldisulfanyl)furan
- 1245820-78-3/1-ethyl-3-methyl-1H-pyrazole-5-sulfonyl chloride
- 1883548-96-6/Liarozole dihydrochloride
- 4144-70-1/2H-Benzotriazole-2-butanoic acid
- 1217863-07-4/Ethyl 2-(4-ethyl-3,5-dimethyl-1H-pyrazol-1-yl)propanoate
- 887360-24-9/6-Amino-1-[3-(trifluoromethyl)phenyl]-1-hexanol
- 1956318-23-2/4-Amino-6-methyl-2H-pyran-2-one hydrochloride
- 859230-84-5/1H-Indole-5-carbonitrile, 3-((1S,2S)-2-((dimethylamino)methyl)cyclopropyl)-, (2Z)-2-butenedioate (1:1)
- 855297-38-0/BMS 505130
- 85140-65-4/Dichloroplatinum;1,3,5,7-tetrazatricyclo[3.3.1.13,7]decane
- 2365172-42-3/(2s,4r)-1-((s)-2-(7-(4-((r)-3-((4-(N-(4-(4-((4'-chloro-4,4-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazin-1-yl)benzoyl)sulfamoyl)-2-((trifluoromethyl)sulfonyl)phenyl)amino)-4-(phenylthio)butyl)piperazin-1-yl)-7-oxoheptanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-((s)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide
- 1219981-06-2/3-Piperidinyl nicotinate hydrochloride
- 474944-25-7/Butenoyl PAF
- 1346746-73-3/1-(2-(N-Methylsulfamoyl)ethyl) naratriptan
- 778647-22-6/1-(2,2,6,6-Tetramethylpiperidin-4-yl)guanidine
- 1241679-42-4/(2S)-2-(3,5-Dibromo-2-methoxyphenyl)pyrrolidine
- 1289388-46-0/tert-Butyl 3-((6-methylpyridazin-3-yl)oxy)piperidine-1-carboxylate
- 40120-02-3/1,2',11'-Tributyl-3a',9a',12a',12b',12c',12d'-hexahydro-1'h,2h,5h-spiro[pyrrolidine-3,9'-pyrrolo[3,4-h]pyrrolo[3',4':3,4]pyrrolo[2,1-a]isoquinoline]-1',2,3',5,10',12'(2'h,4'h,11'h)-hexone
- 1177355-20-2/({1-[(3,5-dimethyl-1H-pyrazol-1-yl)methyl]cyclopropyl}methyl)amine
- 1227597-40-1/2,4-Dichloro-5-methoxypyridine
- 1082208-35-2/Ethyl (2E)-3-(4-methyl-1,3-thiazol-5-yl)-2-[(1H-1,2,4-triazol-1-yl)methyl]prop-2-enoate
- 1179148-81-2/6-Methoxyisoquinoline-1-carboxylic acid
- 1093403-65-6/N-(3-methylbutyl)cyclopropanamine hydrochloride
- 1780283-92-2/tert-Butyl 3-amino-3-(2-hydroxyethyl)azetidine-1-carboxylate